Healthcare -
Biotechnology - NASDAQ - US
$ 6.525
-6.85 %
$ 336 M
Market Cap
-1.78
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Verastem, Inc.
| Net Income | -131 M |
| Depreciation & Amortization | 26 K |
| Capital Expenditures | -28 K |
| Stock-Based Compensation | 7.34 M |
| Change in Working Capital | 3.72 M |
| Others | 21.7 M |
| Free Cash Flow | -105 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||
| Net Income | (130.6) | (87.4) | (73.8) | (71.2) | (67.7) | (149.2) | (72.4) | (67.8) | (36.4) | (57.9) | (53.4) | (41.2) | (32.0) | (13.7) | (0.8) |
| Depreciation & Amortization | 26 K | (0.1) | 36 K | 72 K | 1.3 | 2.2 | 1.4 | 0.6 | 0.7 | 0.8 | 0.4 | 0.2 | 0.2 | 83 K | 0 |
| Deferred Income Tax | 0 | (2.3) | 0 | 0 | 2.9 | 0.6 | (25.6) | 0 | 0 | 0 | 0.3 | 0 | 0 | 13.7 | 0 |
| Stock Based Compensation | 7.3 | 5.9 | 6.0 | 7.7 | 8.1 | 8.5 | 6.7 | 5.0 | 6.3 | 10.1 | 12.4 | 9.7 | 7.4 | 1.6 | 0 |
| Other Operating Activities | 14.8 | (1.6) | 0.2 | 9.3 | 10.3 | 7.1 | 1.8 | 0.2 | (0.1) | 0.3 | 1.2 | 0 | 2.4 | (13.3) | 100 K |
| Change in Working Capital | 3.7 | (1.0) | 3.9 | 0.6 | 11.6 | (7.8) | 13.7 | 4.7 | 0.1 | 1.2 | 2.2 | 5.0 | (0.6) | 1.4 | 0.4 |
| Cash From Operations | (104.8) | (86.5) | (63.7) | (53.5) | (33.5) | (138.5) | (74.5) | (57.3) | (29.5) | (45.6) | (36.9) | (26.3) | (22.6) | (10.1) | (0.3) |
| INVESTING CASH FLOW | |||||||||||||||
| Capital Expenditures | 28 K | 7 K | 0 | (0.2) | 33 K | 7 K | (23.5) | 0 | 39 K | (0.2) | (2.4) | 56 K | (0.3) | (0.8) | 8 K |
| Other Items | 60.0 | (44.5) | 66.2 | 0.3 | (47.3) | 89.6 | (114.9) | 44.0 | 37.0 | (26.8) | 45.6 | (23.3) | (45.5) | (35.9) | 0 |
| Cash From Investing Activities | 60.0 | (44.4) | 66.2 | 87 K | (47.4) | 89.6 | (138.4) | 44.0 | 37.0 | (27.1) | 43.1 | (23.4) | (45.9) | (36.7) | 8 K |
| FINANCING CASH FLOW | |||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 68 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.7) | 0 |
| Total Debt Repaid | (0.1) | 14.6 | 24.1 | 0 | (37.4) | (2.5) | 155.2 | 14.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 40.7 | 28.2 | 0.3 | 0.2 | 0.9 | 63 K | 0.8 | 0.3 | 5 K | (0.4) | (0.8) | (1.3) | 3 K | 64.9 | 0 |
| Cash From Financing Activities | 54.8 | 134.2 | 51.8 | 6.9 | 69.6 | (2.4) | 261.2 | 63.2 | 5 K | 63.6 | 8.8 | 58.5 | 57.6 | 64.2 | 3.9 |
| CHANGE IN CASH | |||||||||||||||
| Net Change In Cash | 10.0 | 3.3 | 54.3 | (46.5) | (11.2) | (51.3) | 48.3 | 49.8 | 7.5 | (9.0) | 15.0 | 8.8 | (10.9) | 17.4 | 0 |
| FREE CASH FLOW | |||||||||||||||
| Free Cash Flow | (104.8) | (86.5) | (63.7) | (53.7) | (33.5) | (138.5) | (98.0) | (57.3) | (29.5) | (45.8) | (39.3) | (26.4) | (22.9) | (10.9) | (0.3) |